Our data suggest that the maintenance of intracellular RGS2 levels is of paramount importance for preventing fibroblast proliferation and transition to the myofibroblast phenotype that drives IPF, adding to our understanding of IPF pathogenesis and treatment. Here, RGS2 is linked to idiopathic pulmonary fibrosis.